Waldenström's macroglobulinemia and bortezomib.
Leblond
Véronique
V
Département d'Hématologie, Hôpital Pitié-Salpêtrière, APHP, Paris, France. veronique.leblond@psl.ap-hop-paris.fr
D001897:Boronic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use*; D016879:Salvage Therapy; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib